Doctors, health experts call on N.S. to cover birth control and HIV-prevention drugAbbey Ferguson with the Halifax Sexual Health Centre says PrEP—an antiviral medication that prevents HIV transmission—is so expensive that many people who would benefit from the drug are not able to take it. Finerenone–empagliflozin superior to either agent alone in patients with CKD and type 2 diabetesStudy compares urinary albumin-to-creatinine ratio with finerenone–empagliflozin versus the single agents alone in patients with chronic kidney disease and type 2 diabetes. It’s time to dive into pharmacogenomics Here’s why pharmacists should lead the way in the emerging field of precision medicine. Breaking the cycle: Lamotrigine and hormonal contraceptive interactions A qualitative study found that 51% of women taking lamotrigine were unaware of the interaction with their COCs. Two new dosage forms physicians and pharmacists should know about Get the info you need on these new dosage forms, part of our drug news roundup for May. NEW DRUG: Lazcluze for nonsmall cell lung cancer Get the info you need on this new drug, part of our drug news roundup for May. Canadian Cardiovascular Society issues update on approaches to smoking cessation Smoking cessation is a fundamental responsibility of every healthcare provider and must be a priority in all healthcare settings. NEW DRUG: Itovebi for breast cancer Get the info you need on this new drug, part of our drug news roundup for May. NEW DRUG: Fabhalta for PNH Get the info you need on this new drug, part of our drug news roundup for May. Diabetes Canada releases updated guideline on chronic kidney disease in diabetes Incorporates new evidence with the aim to prevent end-stage kidney disease in most people with diabetes by adopting health behaviours and use of pharmacologic therapies. First Previous 15 16 17 18 19 Next Last
